|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
3.01(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,004,919 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Buechler Kenneth F |
Director |
|
2019-03-12 |
4 |
S |
$66.50 |
$598,500 |
D/D |
(9,000) |
47,769 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-03-12 |
4 |
OE |
$11.96 |
$107,640 |
D/D |
9,000 |
56,769 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-28 |
4 |
S |
$65.62 |
$1,453,680 |
D/D |
(22,153) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-28 |
4 |
OE |
$12.63 |
$279,792 |
D/D |
22,153 |
323,239 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-27 |
4 |
S |
$65.98 |
$1,461,721 |
D/D |
(22,154) |
301,086 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-27 |
4 |
OE |
$12.63 |
$279,805 |
D/D |
22,154 |
323,240 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-02-27 |
4 |
S |
$66.23 |
$897,458 |
D/D |
(13,551) |
5,191 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-02-27 |
4 |
OE |
$15.40 |
$208,685 |
D/D |
13,551 |
18,647 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-26 |
4 |
S |
$65.72 |
$2,066,434 |
D/D |
(31,443) |
301,086 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-26 |
4 |
OE |
$12.63 |
$452,563 |
D/D |
31,443 |
332,529 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-02-25 |
4 |
S |
$68.44 |
$167,600 |
D/D |
(2,449) |
5,096 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-02-25 |
4 |
OE |
$15.40 |
$37,715 |
D/D |
2,449 |
7,545 |
|
- |
|
Brown Thomas D |
Director |
|
2019-02-22 |
4 |
S |
$67.53 |
$1,156,249 |
D/D |
(17,122) |
53,958 |
|
- |
|
Brown Thomas D |
Director |
|
2019-02-22 |
4 |
OE |
$21.07 |
$382,014 |
D/D |
17,122 |
71,080 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2019-02-22 |
4 |
S |
$67.50 |
$2,639,460 |
D/D |
(39,103) |
19,459 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2019-02-22 |
4 |
OE |
$23.41 |
$915,401 |
D/D |
39,103 |
58,562 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-02-20 |
4 |
S |
$70.17 |
$1,013,863 |
D/D |
(14,449) |
9,207 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-19 |
4 |
S |
$65.01 |
$975,182 |
D/D |
(15,000) |
29,685 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-02-15 |
4 |
S |
$65.12 |
$896,885 |
D/D |
(13,772) |
23,656 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-02-15 |
4 |
S |
$65.00 |
$565,890 |
D/D |
(8,706) |
5,428 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-02-14 |
4 |
S |
$65.00 |
$962,455 |
D/D |
(14,807) |
14,134 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-02-14 |
4 |
OE |
$24.68 |
$365,437 |
D/D |
14,807 |
28,941 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-11 |
4 |
D |
$60.75 |
$52,427 |
D/D |
(863) |
15,896 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,593 |
16,106 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-11 |
4 |
D |
$60.75 |
$54,007 |
D/D |
(889) |
44,685 |
|
- |
|
1127 Records found
|
|
Page 14 of 46 |
|
|